Predictors of treatment failure in severe pneumonia treated with Ampicillin in tertiary care center
DOI:
https://doi.org/10.18203/2349-3291.ijcp20191479Keywords:
Ampicillin, Anemia, Hypoxia, Immunization, Moderate acute malnutrition, Pneumonia, Rickets, Severe treatment failureAbstract
Background: Pneumonia affects 156 million children under five years every year and is the leading cause of mortality in this age group. It emphasizes the need to identify high risk factors for Treatment Failure so as to treat them aggressively. The objective of this study was to assess factors influencing treatment failure in severe pneumonia treated with Ampicillin.
Methods: Prospective observational study, in which 235 children with severe pneumonia between 2 months to 60 months were enrolled and started with intravenous Ampicillin as per WHO protocol. If no clinical improvement was seen after 48 hours, it was taken as treatment failure and managed accordingly.
Results: Among 235 children, 43(18.2%) did not respond to Ampicillin. Among treatment failure cases males were 20 (46.5%) and females were 23 (53.6%). All the following parameters were statistically significant(p<0.05). Majority of 23(53.4%) were between 2 to 12 months. 13(30.2%) were incompletely immunized. MAM were 23(53.4%) and 22(51.1%) cases had signs of Rickets. 34(79.1%) had Anemia out of which 22(64%) had moderate anemia. 39(90.6%) children had fever and hypoxia at admission.
Conclusions: Infancy, malnutrition, severity of anemia, rickets, lack of immunization, hypoxia at baseline were significant predictors of treatment failure in severe pneumonia. Strengthening immunization and improving nutritional status may improve the outcome. Children with above risk factors require vigilant monitoring.
References
Bryce J, Boschi-Pinto C, Shibuya K, Black RE, WHO child health epidemiology reference group. WHO estimates of the causes of death in children. Lancet. 2005;365(9465):1147-52.
Sazawal S, Black RE. Effect of pneumonia case management on mortality in neonates, infants, and preschool children: a meta-analysis of community-based trials. Lancet Infect Dis. 2003;3:547-56.
Hazir T, Fox LM, Nisar YB, Fox MP, Ashraf YP, MacLeod WB, et al. New outpatient short-course home oral therapy for severe pneumonia study Group. Ambulatory short-course high-dose oral amoxicillin for treatment of severe pneumonia in children: a randomised equivalency trial. Lancet. 2008;371(9606):49-56.
Basis for WHO recommendations on the management of pneumonia in children at first level health facilities. WHO/ARI/91.20 Geneva: World health organization; 1991. Available at: https://www.who.int > ari_91_20.
El-Radhi AS, Barry W. Thermometry in paediatric practice. Arch Dis Child. 2006;91:351-6.
Jayashree M, Singhi S. Initial Assessment and Triage in ER. Indian J Pediat. 2011:1100-8.
Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Accessed at: https://apps.who.int/iris/handle/10665/85839.
Patwari AK. Nutrition: A Parthasarathy, Ed, IAP textbook of Pediatrics, 6th ed. New Delhi: Jaypee. 2016:152-75.
McNally LM, Jeena PM, Gajee K, Thula SA, Sturm AW, Cassol S, et al. Effect of age, polymicrobial disease, and maternal HIV status on treatment response and cause of severe pneumonia in South African children: a prospective descriptive study. Lancet. 2007;369(9571):1440-51.
Addo-Yobo E, Chisaka N, Hassan M, Hibberd P, Lozano JM, Jeena P, et al. Oral amoxicillin versus injectable penicillin for severe pneumonia in children aged 3 to 59 months: a randomised multicentre equivalency study. Lancet. 2004;364(9440):1141-8.
Fu LY, Ruthazer R, Wilson I, Patel A, Fox LM, Tuan TA, et al. Brief hospitalization and pulse oximetry for amoxycillin treatment failure in severe pneumonia. Pediat. 2006;118:e1822-30.
Asghar R, Banajeh S, Egas J, Hibberd P, Iqbal I, Katep-Bwalya M, et al. Multicentre randomized controlled trial of chloramphenicol vs. ampicillin and gentamicin for the treatment of very severe pneumonia among children aged 2 to 59 months in low resource settings: a multicenter randomized trial (spear study). BMJ. 2008;336:80-4.
Jain DL, Sarathi V, Jawalekar S. Predictors of treatment failure in hospitalized children (3–59 months) with severe and very severe pneumonia. Indian Pediat. 2013;50(8):787-9.
Haugen J, Basnet S, Hardang IM, Sharma A, Mathisen M, Shrestha P, et al. Vitamin D status is associated with treatment failure and duration of illness in Nepalese children with severe pneumonia. Pediatr Res. 2017;82(6):986.
Oduwole AO, Renner JK, Disu E, Ibitoye E, Emokpae E. Relationship between vitamin D levels and outcome of pneumonia in children. West African J Med. 2010;29(6).
Mamani M, Muceli N, Ghasemi Basir HR, Vasheghani M, Poorolajal J. Association between serum concentration of 25-hydroxy vitamin D and community acquired pneumonia. Int. J Gen Med. 2017:10;423-29.
Wayse V, Yousafzai A, Mogale K, Filteau S. Association of subclinical vitamin D deficiency with severe acute lower respiratory infection in Indian children under 5 y. European J Clinic Nutrit. 2004;58(4):563.
Pletz MW, Terkamp C, Schumacher U, Rohde G, Schütte H, Welte T, et al. Vitamin D deficiency in community-acquired pneumonia: low levels of 1, 25 (OH) 2 D are associated with disease severity. Respiratory Res. 2014;15(1):53.
Sakka ASE, Iman SS, Amer HA, Moustafa SA. Vitamin D deficiency and: Egypt Pediatr Assoc Gaz. 2014;62:1-7.
Moschovis PP, Banajeh S, MacLeod WB, Saha S, Hayden D, Christiani DC, et al. Childhood anemia at high altitude: risk factors for poor outcomes in severe pneumonia. Pediatr. 2013;132(5):e1156-62.
